Latest News

Date Title Topic
13 Jul 2017 A decade after completion of the HERA trial: where are we in the adjuvant treatment of patients with HER2-positive early breast cancer? Breast cancer
13 Jul 2017 The EU-Funded MiRoR Project Will Transform Clinical Research Practice and Increase its Value Bioethics, legal and economic issues
12 Jul 2017 NICE Terminates Appraisals for Daratumumab with Lenalidomide and Dexamethasone, Bortezomib in Relapsed Multiple Myeloma, and Ibrutinib for Untreated CLL Haematologic malignancies - Anticancer agents & Biologic therapy
11 Jul 2017 FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease Cancer in Special Situations - Haematologic malignancies
10 Jul 2017 First-Line Nivolumab in Stage IV or Recurrent NSCLC with a PD-L1 Expression Level of 5% or More Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
07 Jul 2017 FDA Grants Marketing Approval to the Praxis Extended RAS Panel Personalised medicine - Anticancer agents & Biologic therapy
06 Jul 2017 NICE Develops a Medtech Innovation Briefing on L-Dex U400 for Lymphoedema After Breast Cancer Treatment Breast cancer - Diagnosis, Imaging and Staging
05 Jul 2017 Metastatic Colorectal Cancer: Beyond RAS and BRAF Translational research - Gastrointestinal cancers
Congress Scarf Contest
04 Jul 2017 EMA Recommends Extension of Indications for Fulvestrant Breast cancer - Anticancer agents & Biologic therapy
04 Jul 2017 ESMO/ACF Patient Guide in Gliomas Now Available Also in French
eUpdate – Treatment Recommendation
03 Jul 2017 ESMO/ACF Patient Guide in Soft Tissue Sarcomas Now Available Also in Japanese
03 Jul 2017 FDA Approves Betrixaban for the Prophylaxis of VTE in Adult Patients Palliative and supportive care
01 Jul 2017 World GI 2017 Press Release: Right-sided Colorectal Tumours: An Internal Radiation Advantage Gastrointestinal cancers